STAT3 and glioblastoma: Certain studies have concluded that it may be caused by STEAP3 activating the TfR-STAT3 pathway in GBM, and that knockdown of the transferrin receptor (TfR) significantly influences the impact of STEAP3 overexpression on malignant phenotypes in GSCs (42, 43).